Asset
AUTOGENE CEVUMERAN
BioNTech SE American Depositary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04486378 | phase2 | active_not_recruiting | 2021-03-08 | 2026-11-01 | BioNTech SE | A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer |
FDA applications (0)
This company has no applications containing this asset.